iANTHUS CAPITAL HOLDINGS (ITHUF) Amortizatization of Intangibles (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Amortizatization of Intangibles came in at $1.1 million in Q1 2026, down 4.88% year-on-year from $1.2 million in Q1 2025, and down 9.59% quarter-over-quarter from $1.3 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $1.1 million for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $1.1 million, down 4.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 1.9% YoY), and the FY2025 annual result was $4.9 million, up 5.73% from the prior year.
- Amortizatization of Intangibles came in at $1.1 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $1.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q4 2025 to a low of $766000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $1.1 million (2024), against an average of $1.1 million.
- Peak annual rise in Amortizatization of Intangibles reached 32.99% in 2022, while the deepest fall reached 84.21% in 2022.
- iANTHUS CAPITAL HOLDINGS's Amortizatization of Intangibles stood at $1.0 million in 2022, then decreased by 2.43% to $1.0 million in 2023, then grew by 19.52% to $1.2 million in 2024, then advanced by 4.25% to $1.3 million in 2025, then dropped by 9.59% to $1.1 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |